BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

425 related articles for article (PubMed ID: 16097092)

  • 1. Challenges in regulating breakthrough medical devices.
    Muni NI; Gross TP; Boam AB; Wang S; Zuckerman BD
    Food Drug Law J; 2005; 60(2):137-42. PubMed ID: 16097092
    [No Abstract]   [Full Text] [Related]  

  • 2. Medical device recall authority--FDA. Final rule.
    Fed Regist; 1996 Nov; 61(225):59004-22. PubMed ID: 10163116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medical device reporting: issues with Class III medical devices.
    Zigler J; Walsh J; Zigler J
    Food Drug Law J; 2007; 62(3):573-80. PubMed ID: 17915398
    [No Abstract]   [Full Text] [Related]  

  • 4. The FDA moves to implement the Safe Medical Devices Act.
    Tamborlane T
    Healthspan; 1992 Nov; 9(10):7-10. PubMed ID: 10122957
    [No Abstract]   [Full Text] [Related]  

  • 5. FDA spells out new reporting requirements.
    Infante M
    Contemp Longterm Care; 1996 Mar; 19(3):60-1. PubMed ID: 10156261
    [No Abstract]   [Full Text] [Related]  

  • 6. Medical device reporting: manufacturer reporting, importer reporting, user facility reporting, distributor reporting. Food and Drug Administration, HHS. Final rule.
    Fed Regist; 2000 Jan; 65(17):4112-21. PubMed ID: 11010653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FDA issues final medical device reporting regulation.
    Healthc Hazard Mater Manage; 1996 Feb; 9(5):5-6. PubMed ID: 10154800
    [No Abstract]   [Full Text] [Related]  

  • 8. Medical devices post-approval studies program: vision, strategies, challenges and opportunities.
    Marinac-Dabic D; Bonhomme M; Loyo-Berrios N; Gross T; Ciperson R; Gardner S; Marcarelli M
    Food Drug Law J; 2007; 62(3):597-604. PubMed ID: 17915402
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmaceuticals and medical devices: medical devices.
    ; Berry MD
    Issue Brief Health Policy Track Serv; 2012 Jan; ():1-38. PubMed ID: 22403842
    [No Abstract]   [Full Text] [Related]  

  • 10. Postmarket surveillance. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2002 Jun; 67(109):38878-92. PubMed ID: 12053947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medical devices: reports of corrections and removals; delay of effective data--FDA. Direct final rule; delay of effective date.
    Fed Regist; 1998 Nov; 63(222):63983. PubMed ID: 10339047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Feds do it again. The EMS community grows wary--and weary--of FDA intervention.
    Nordberg M
    Emerg Med Serv; 1995 Mar; 24(3):40-52. PubMed ID: 10140757
    [No Abstract]   [Full Text] [Related]  

  • 13. Who should protect the public? The Supreme Court and medical device regulation.
    Korobkin R
    N Engl J Med; 2007 Oct; 357(17):1680-1. PubMed ID: 17960010
    [No Abstract]   [Full Text] [Related]  

  • 14. FDA marketing claims, and the practitioner.
    Runner S
    J Evid Based Dent Pract; 2006 Mar; 6(1):19-23. PubMed ID: 17138391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myths and realities in medical packaging.
    Pilchik R
    Med Device Technol; 2003 Mar; 14(2):16-7. PubMed ID: 12698692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medical devices; medical device user facility and manufacturer reporting, certification and registration; Office of Management and Budget approval; extension of effective date--FDA. Final rule; notification of approval of information collection requirements.
    Fed Regist; 1996 Apr; 61(71):16043-5. PubMed ID: 10157704
    [No Abstract]   [Full Text] [Related]  

  • 17. Devices and the food and drug administration.
    Phillips SJ; Phillips RS
    Artif Organs; 2005 May; 29(5):363-5. PubMed ID: 15854210
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmaceuticals and medical devices: medical devices.
    Berry MD
    Issue Brief Health Policy Track Serv; 2013 Dec; ():1-49. PubMed ID: 24482892
    [No Abstract]   [Full Text] [Related]  

  • 19. Facilities' responsibilities after notification of a medical device hazard or recall.
    Health Devices; 2004 Sep; 33(9):339. PubMed ID: 15532863
    [No Abstract]   [Full Text] [Related]  

  • 20. The Food and Drug Administration's regulation of risk disclosure for implantable cardioverter defibrillators: has technology outpaced the Agency's regulatory framework?
    Basile EM; Lorell BH
    Food Drug Law J; 2006; 61(2):251-72. PubMed ID: 16903031
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 22.